日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Surufatinib plus tislelizumab as later-line therapy for metastatic colorectal cancer: a single-arm, phase II trial

苏鲁替尼联合替雷利珠单抗作为转移性结直肠癌的二线治疗：一项单臂 II 期试验

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-026-15705-z
Xu, Huijun; Yan, Ying; Niu, JiaYu; Cao, Lulu; Chen, Wenju; Li, Mengge; Luo, Huiqin; Ke, Lihong; Wu, Shusheng; Wang, Gang; He, Yifu
肿瘤
肠癌
肿瘤免疫
发表日期：2026
文献求助 收藏

GCLC desuccinylation regulated by oxidative stress protects human cancer cells from ferroptosis.

氧化应激调节的 GCLC 去琥珀酰化可保护人类癌细胞免于铁死亡

期刊:Cell Death and Differentiation
影响因子:15.4
doi:10.1038/s41418-025-01505-8
Chen Zixiang, Niu Kaifeng, Li Mengge, Deng Yuchun, Zhang Ji, Wei Di, Wang Jiaqi, Zhao Yongliang
细胞生物学
Human
氧化应激
铁死亡
发表日期：2025
文献求助 收藏

Analysis of hepatitis B virus integration identifies KMT2B as a novel cancer-related gene in pancreatic cancer

对乙型肝炎病毒整合的分析发现，KMT2B是胰腺癌中一种新的癌症相关基因。

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70424
Li, Mengge; Li, Huimin; Liu, Dejun; Liu, Shunan; Yuan, Hui; Wu, Yan; Du, Min; Fang, Yuan; Li, Jin; Cong, Hui; Zhao, Dan; Fan, Chunsun; Wang, Qing; Shen, Cenkai; Gan, Yu; Sun, Yongwei; Tu, Hong
肿瘤
肿瘤免疫
微生物学
胰腺癌
KMT2B
肝炎
发表日期：2025
文献求助 收藏

Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances

肝细胞癌的免疫微环境和免疫疗法：机制与进展

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1581098
Xie, Dong; Liu, Yang; Xu, Fangbiao; Dang, Zhibo; Li, Mengge; Zhang, Qinsheng; Dang, Zhongqin
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

USP33 Regulates DNA Damage Response and Carcinogenesis Through Deubiquitylating and Stabilising p53.

USP33 通过去泛素化和稳定 p53 来调节 DNA 损伤反应和致癌作用

期刊:Cell Proliferation
影响因子:5.6
doi:10.1111/cpr.13793
Zhu Yuqi, Chen Zixiang, Niu Kaifeng, Li Mengge, Deng Yuchun, Zhang Ji, Wei Di, Wang Jiaqi, Zhao YongLiang
肿瘤
P53
泛素化
发表日期：2025
文献求助 收藏

Genome assembly of Stewartia sinensis reveals origin and evolution of orphan genes in Theaceae

中华斯图尔特树（Stewartia sinensis）基因组组装揭示了山茶科孤儿基因的起源和演化

期刊:Communications Biology
影响因子:5.1
doi:10.1038/s42003-025-07525-x
Cheng, Lin; Han, Qunwei; Hao, Yanlin; Qiao, Zhen; Li, Mengge; Liu, Daliang; Yin, Hao; Li, Tao; Long, Wen; Luo, Shanshan; Gao, Ya; Zhang, Zhihan; Yu, Houlin; Sun, Xinhao; Li, Hao; Zhao, Yiyong
发表日期：2025
文献求助 收藏

HBV DNA integration gene CCDC91 is oncogenic and a potential therapeutic target for hepatocellular carcinoma.

HBV DNA整合基因CCDC91具有致癌性，是肝细胞癌的潜在治疗靶点

期刊:Communications Biology
影响因子:5.1
doi:10.1038/s42003-025-08369-1
Li Mengge, Wu Shusheng, Luo Huiqin, Niu Jiayu, Fang Yuan, Chen Wenju, Cao Lulu, He Yifu
细胞生物学
发表日期：2025
文献求助 收藏

Preparation of Polypyrrole/Montmorillonite/Polypropylene Composite Membranes and Investigation of Their Adsorption Performance for Methyl Orange and Pb(2)

聚吡咯/蒙脱石/聚丙烯复合膜的制备及其对甲基橙和Pb(2)吸附性能的研究

期刊:Polymers
影响因子:4.9
doi:10.3390/polym17091158
Wang, Baoxin; Xu, Binbin; Chen, Gaofeng; Wang, Chaozhong; Liu, Yang; Bai, Yang; Li, Mengge; Peng, Longgui
发表日期：2025
文献求助 收藏

Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients

卡瑞利珠单抗联合阿帕替尼和伊立替康作为晚期或转移性食管鳞状细胞癌患者的二线治疗方案

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14207-8
Wu, Shusheng; Luo, Huiqin; Chen, Wenju; Liu, Xudong; Li, Huimin; Li, Mengge; Ke, Lihong; Niu, Jiayu; Hu, Bing; Xu, Huijun; Wang, Gang; Yan, Ying; Cao, Lulu; Hu, Xiaoxiu; Li, Chenghui; He, Yifu
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

A machine learning model utilizing CT radiomics features and peripheral blood inflammatory markers predicts the prognosis of patients with unresectable esophageal squamous cell carcinoma undergoing PD-1 inhibitor combined with concurrent chemoradiotherapy

利用CT放射组学特征和外周血炎症标志物的机器学习模型预测接受PD-1抑制剂联合同步放化疗的不可切除食管鳞状细胞癌患者的预后

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.105171
Liu, Xudong; Gao, Fei; Wu, Shusheng; Wang, Haoyu; Dang, Wenxi; Sun, Mingjie; Zhang, Zhihua; Li, Mengge; Cai, Zhirun; Li, Wen; He, Yifu
肿瘤
炎症
肿瘤免疫
炎症/感染
细胞生物学
PD-1
发表日期：2025
文献求助 收藏